Table 1.
Baseline Demographic and Clinical Characteristics of the Patients
Variable | DSA I+ (n=4) | DSA II+ (n=11) | DSA− (n=34) |
---|---|---|---|
Recipient age, years | 56.7 [44.8, 69.7] | 51.7 [47.9, 60.4] | 55.3 [46.9, 61.5] |
Gender—male, n(%) | 3(75) | 9(82) | 26(76) |
Time from transplant to 1st IVUS (years) | 0.99 [0.36, 1.15] | 0.20 [0.18, 1.05] | 0.62 [0.18, 1.22] |
Time between IVUS exams | 1.00 [0.95, 1.05] | 0.84 [0.76, 0.92] | 0.96 [0.84, 1.06] |
ICMP, n(%) | 0(0)* | 5(45) | 7(21) |
Donor age (years) | 21.5 [20.0, 33.2] | 21 [17.0, 29.0] | 30.7 [22.1, 46.7] |
Ischemic time (min) | 161.5 [158.0, 173.4] | 185 [160.0, 240.0] | 183.0 [131.2, 210.7] |
BMI (kg/m2) | 22.8 [20.4, 24.0] | 27.3 [21.6, 31.9] | 26.0 [22.2, 29.5] |
Uric acid (mg/dL) | 5.9 [5.2, 6.2] | 6.8 [5.7, 9.2] | 7.1 [5.6, 9.4] |
GFR mL/min/1.73 m2 | 48.5 [37.8, 56.2] | 60.0 [48.0, 79] | 57.0 [43.0, 63.0] |
Triglycerides (mg/dL) | 76.5 [62.7, 187] | 136.5 [87.5, 209.7] | 112.0 [73.0, 218.3] |
Cholesterol (mg/dL) | 151.0 [111.0, 218.0] | 156.0 [116.0, 195.0] | 174.0 [135.0, 204.7] |
Hypertension, n(%) | 1(25) | 2(18) | 8(23) |
Diabetes, n(%) | 0(0) | 2(18) | 4(13) |
Total rejection score | 0.34 [0.24, 0.47] | 0.23 [0.0, 0.5] | 0.20 [0.0, 0.4] |
Any rejection score | 0.31 [0.18, 0.47] | 0.23 [0.0, 0.5] | 0.20 [0.0, 0.4] |
Peak DSA (MFI) | 1278 [482, 2051] | 804 [530, 2221] | 0 [0, 0] |
Positive flow cytometric crossmatch n(%)|| | 0(0)* | 6(60)*¶ | 0(0)¶ |
CCB, n(%) | 1(25) | 3(27) | 9(27) |
Statin n(%) | 2(50) | 8(72) | 24(71) |
Aspirin, n(%) | 1(25) | 5(45) | 8(23) |
SRL vs CNI n(%) | SRL 3(75); CNI 1(25) | SRL 8(72); CNI 3(28) | SRL 14(42); CNI 20(58) |
MMF vs AZA, n(%) | MMF 3(75); AZA 1(25) | MMF 9(82); AZA 2(18) | MMF 24(71); AZA 10(29) |
Prednisone, n(%) | 3(75) | 8(72) | 17(50) |
P<0.05, DSA I+ vs. DSA II+; + P<0.05, DSA I+ vs. DSA−.;
P<0.05, DSA II+ vs. DSA−
Assessed in 17 DSA−, 3 DSAI+ and 10 DSA II+ patients.